UCC/UGC/YCC
Proposal for New Course
1. Effective BEGINNING of what term and year?:
Fall 2012
See effective dates calendar.
2. College: Health and Human
Services
4. Course subject and number:
3. Academic Unit: Physician Assistant Studies
PHA 551
5. Units: 3
6. Long course title: Pharmacology and Pharmacotherapeutics II
(max 100 characters including spaces)
7. Short course title: Phrmclgy Phrmcthrptcs II
(max. 30 characters including spaces)
8. Catalog course description (max. 60 words, excluding requisites):
The course will focus on the general principles of pharmacology and the application of these
principles to pharmacotherapeutics and patient care situations. Students will learn the classes
of pharmaceuticals with a focus on the mechanisms of action, common side effects, adverse
reactions and interactions for the commonly prescribed medications in musculoskeletal,
rheumatologic, gastrointestinal, endocrine, male and female reproductive, and
hematology/oncology. 3 units lecture
9. Grading option:
Letter grade
Pass/Fail
Both
10a. UGC approval date*: N/A
10. Co-convened with: N/A
(For example: ESE 450 and ESE 550)
*Must be approved by UGC before UCC submission, and both course syllabi must be presented
11. Cross-listed with:
N/A
(For example: ES 450 and DIS 450)
Please submit a single cross-listed syllabus that will be used for all cross-listed courses.
Revised 06/22/2011
1
12. May course be repeated for additional units?
12a. If yes, maximum units allowed?
12b. If yes, may course be repeated for additional units in the same term?
13. Prerequisites:
PHA 550
14. Co requisites:
N/A
Yes
No
Yes
No
15. Is this course in any plan (major, minor or certificate) or sub plan (emphasis or concentration)?
Yes
No
If yes, describe the impact and attach written responses from the affected academic units prior
to college curricular submission.
PHA 551 is a required course in the Master of Physician Assistant Studies.
16. Is there a related plan or sub plan proposal being submitted?
If no, explain.
Yes
No
17. Does this course include combined lecture and lab components?
Yes
If yes, note the units specific to each component in the course description above.
No
18. Does this course duplicate content of existing courses?
Yes
No
If yes, list the courses with duplicate material. If the duplication is greater than 20%,
explain why NAU should establish this course.
19. Names of the current faculty qualified to teach this course:
Steven Curry, MD
20. Justification for new course.
This course is a part of the new Master of Physician Assistant Studies degree and meets the
ARC-PA accreditation standards for curriculum
Answer 21-22 for UCC/YCC only:
21. Is this course being proposed for Liberal Studies designation?
Yes
If yes, forward this form along with the appropriate supporting documentation to the
Liberal Studies Committee.
Revised 06/22/2011
No
2
22. Is this course being proposed for Diversity designation?
Yes
If yes, forward this form along with the appropriate supporting documentation to the
Diversity Committee
Scott Galland
Reviewed by Curriculum Process Associate
No
09/20/2011
Date
Approvals:
Department Chair/ Unit Head (if appropriate)
Date
Chair of college curriculum committee
Date
Dean of college
Date
For Committee use only:
UCG/UGC/YCC Approval
Date
:
Approved as submitted:
Yes
No
Approved as modified: Yes
No
:
:
Please attach proposed Syllabus in approved university format.
Revised 06/22/2011
3
Department of Physician Assistant Studies
PHA 551 Pharmacology and Pharmacotherapeutics II Syllabus
3 Credits, 48 Clock Hours
3 credits of lecture (4 hours of contact time/week over 12 weeks)
Instructor of Record: Steven Curry, MD
Office Address: TBD
Office Hours: TBD
Course Time and Location: Class will meet for lecture 4 hours per week on X days. Part of the
lecture time will be devoted to lectures focusing on the clinical application of
pharmacotherapeutics. Please see the attached weekly calendar for more details. Lecture is from
X-X time.
Course Prerequisites: PHA 550 Pharmacology and Pharmacotherapeutics I
Course Description:
Pharmacology is the study of drugs and how they interact with physiological systems and
pharmacotherapeutics is the study of the therapeutic uses and effects of drugs. This two semester
lecture course series will introduce the students to the general principles of pharmacology,
specifically pharmacokinetics (absorption, distribution, metabolism, and excretion) and
pharmacodynamics (drug receptor interactions, dose response curves, agonist and antagonist
drugs) and the concepts of therapeutic and drug product selection, including issues of efficacy,
potential toxicities, compliance, monitoring parameters, drug interactions, and cost. A rational
and evidence based approach to the selection of medications to be prescribed, and studies of
medications used in the treatment of acute and chronic illnesses across the lifespan will be
presented. Pharmacology and Pharmacotherapeutics I and II will run concurrently with
Foundations of Clinical Practice II and III and will focuses on the therapeutics associated with
disease states presented in those respective courses. Some information will be presented in a case
study format using patient scenarios to develop clinical pharmacology knowledge. In addition,
this course presents a review of the principles of pharmacology and examines legal and
professional issues in prescribing.
The second of two the courses, Pharmacology and Pharmacotherapeutics II will build upon the
general principles of pharmacology with a stronger emphasis in applying this knowledge to
selection of pharmacological agents in the treatment of diseases and conditions. Classes of
pharmaceuticals will be studied, with a focus on the mechanisms of drug action in different
therapeutic classes, common side effects of prototypic drugs in each category, drug side effects,
adverse reactions and interactions for the commonly prescribed medications in the diseases and
conditions covered in Foundations of Clinical Practice III.
Revised 06/22/2011
4
Student Learning Expectations/Outcomes for this Course:
Student Learning Outcomes: Upon completion of this course, through written examinations,
class participation, and course readings and/or assignments, the student will be able to:
1. Identify and apply basic principles of pharmacology, including: pharmacokinetics,
pharmacodynamics, receptors, dose-response, and drug interactions as it relates to the
selection of medications for medical diseases and conditions.
2. Identify the major classes of drugs and the specific drugs within them and their therapeutic
uses in the treatment of the following organ systems covered in Foundations of Clinical
Practice III: musculoskeletal/rheumatologic, gastrointestinal, endocrine, reproductive,
hematology/oncology, and pediatrics.
3. Identify and apply the basic properties, routes of administration, relative half-lives, target
organ (or system), and mechanisms of action of commonly used drugs from each of the organ
systems covered in Foundations of Clinical Practice III: musculoskeletal/rheumatologic,
gastrointestinal, endocrine, reproductive, hematology/oncology, and pediatrics.
4. Apply the principles of clinical pharmacotherapeutics for the classes of drugs covered in this
course, to include the appropriate choice of drugs, therapeutic uses, their safe dose schedule
and route of administration, adverse drug interactions, side effects, and cost-effectiveness.
5. Demonstrate clinical reasoning and an evidence based approach to the selection choice of
commonly used medications for the organ system disease states covered in the course.
Course Structure/Approach:
Two hour weekly lectures will be presented in pharmacokinetics and pharmacodynamics with an
additional weekly hour lecture in clinical application of pharmacotherapy.
Textbooks and Resources:
Golan, D., Tashjian, A.H., Armstrong, E.J., & Armstrong, A.W. (2008). Principles of
pharmacology: The pathophysiologic basis of drug therapy (2nd ed.). Philadelphia, PA:
Lippincot, Williams & Wilkins. (Revised edition will be available prior to course start)
Course Outline: (with Instructional Objectives)
Week 1: Musculoskeletal/Rheumatology Drugs
Week 2: Pain Management
Week 3: Gastrointestinal Drugs I
Week 4: Gastrointestinal Drugs II
Week 5: Endocrine Drugs I
Week 6: Endocrine Drugs II
Week 7: Reproductive (OB/GYN Drugs, Women’s GU)
Week 8: Reproductive (Men’s GU)
Week 9: Hematology/Oncology Drugs I
Week 10: Hematology/Oncology Drugs II
Week 11: Herbal Medications
Revised 06/22/2011
5
Week 12: Pediatric Drug Dosing
Assessment of Student Learning Outcomes:
Students will be evaluated through:
Four written examinations utilizing multiple choice format;
must achieve a score of 80% to pass
Written Exam 1 (E1)
Written Exam 2 (E2)
Written Exam 3 (E3)
Written Exam 4 (E4)
25%
25%
25%
25%
100%
Students will take the exam on the NAU Phoenix Bio-Medical Campus.
Grading System:
The following grading scale will be used:
A
B
C
F
90-100
80-89
70-79
≤69
Course policy:
Retests/make-up exams: Make-up exams will not be offered unless you can demonstrate (e.g.,
with a doctor’s letter) that your absence on the exam day was unavoidable.
Attendance: Attendance in lecture and laboratory is mandatory due to the material presented.
Please refer to the NAU DPAS Student Handbook on policies on attendance.
Student Responsibilities
Students are expected to attend all classes and to read the defined reading assignments as stated
on the instructional objectives prior to class. This will facilitate comprehension of the material
presented in lecture. Students are also expected to take all examinations as defined by the course.
The program expects all students to consistently conduct themselves in a professional manner, to
demonstrate respect, compassion and integrity, sensitivity to differences in all interactions and to
demonstrate emotional resiliency, stability, flexibility and tolerance of ambiguity and anxiety.
All cell phones and electronic devices must be turned off and out of sight during exams. If a
student is found with a cell phone out during an exam, the student will receive an immediate
grade of zero for the exam, and potentially further disciplinary action.
NAU Policy on Academic Dishonesty:
ACADEMIC DISHONESTY is a form of misconduct that is subject to disciplinary action
under the Student Code of Conduct and includes the following: cheating, fabrication, fraud,
facilitating academic dishonesty and plagiarism.
Revised 06/22/2011
6
Plagiarism: any attempt to knowingly or deliberately pass off other's work as your own.
Cheating: any attempt to gain an unfair advantage over one's fellow students.
Fabrication: any attempt to present information that is not true when the author knows the
information presented is false.
Fraud: any attempt to deceive an instructor or administrative officer of the university.
Facilitating Academic Dishonesty: any attempt to assist an act of academic dishonesty by
another individual.
If you are charged with academic dishonesty, you are subject to the Arizona Board of Regents’
Student Code of Conduct and procedures established by NAU, specifically the Academic
Dishonesty policy, outlined in the http://www4.nau.edu/stulife/handbook.htm.
University policy:
SAFE ENVIRONMENT POLICY NAU’s Safe Working and Learning Environment Policy
seeks to prohibit discrimination and promote the safety of all individuals within the university.
The goal of this policy is to prevent the occurrence of discrimination on the basis of sex, race,
color, age, national origin, religion, sexual orientation, disability, or veteran status and to prevent
sexual harassment, sexual assault or retaliation by anyone at this university.
You may obtain a copy of this policy from the college dean’s office or from the NAU’s
Affirmative Action website http://home.nau.edu/diversity/. If you have concerns about this
policy, it is important that you contact the departmental chair, dean’s office, the Office of
Student Life (928-523-5181), or NAU’s Office of Affirmative Action (928-523-3312).
STUDENTS WITH DISABILITIES If you have a documented disability, you can arrange for
accommodations by contacting Disability Resources (DR) at 523-8773 (voice)or 523-6906
(TTY), dr@nau.edu (e-mail)or 928-523-8747 (fax).Students needing academic accommodations
are required to register with DR and provide required disability related documentation. Although
you may request an accommodation at any time, in order for DR to best meet your individual
needs, you are urged to register and submit necessary documentation (www.nau.edu/dr) 8 weeks
prior to the time you wish to receive accommodations. DR is strongly committed to the needs of
student with disabilities and the promotion of Universal Design. Concerns or questions related to
the accessibility of programs and facilities at NAU may be brought to the attention of DR or the
Office of Affirmative Action and Equal Opportunity (523-3312).
INSTITUTIONAL REVIEW BOARD Any study involving observation of or interaction with
human subjects that originates at NAU—including a course project, report, or research paper—
must be reviewed and approved by the Institutional Review Board (IRB) for the protection of
human subjects in research and research-related activities.
The IRB meets monthly. Proposals must be submitted for review at least fifteen working days
before the monthly meeting. You should consult with your course instructor early in the course
to ascertain if your project needs to be reviewed by the IRB and/or to secure information or
appropriate forms and procedures for the IRB review. Your instructor and department chair or
college dean must sign the application for approval by the IRB. The IRB categorizes projects
into three levels depending on the nature of the project: exempt from further review, expedited
review, or full board review. If the IRB certifies that a project is exempt from further review, you
Revised 06/22/2011
7
need not resubmit the project for continuing IRB review as long as there are no modifications in
the exempted procedures.
A copy of the IRB Policy and Procedures Manual is available in each department’s
administrative office and each college dean’s office or on their website:
http://www.research.nau.edu/vpr/IRB/index.htm. If you have questions, contact the IRB
Coordinator in the Office of the Vice President for Research at 928-523-8288 or 523-4340.
ACADEMIC INTEGRITY The university takes an extremely serious view of violations of
academic integrity. As members of the academic community, NAU’s administration, faculty,
staff and students are dedicated to promoting an atmosphere of honesty and are committed to
maintaining the academic integrity essential to the education process. Inherent in this
commitment is the belief that academic dishonesty in all forms violates the basic principles of
integrity and impedes learning. Students are therefore responsible for conducting themselves in
an academically honest manner.
Individual students and faculty members are responsible for identifying instances of academic
dishonesty. Faculty members then recommend penalties to the department chair or college dean
in keeping with the severity of the violation. The complete policy on academic integrity is in
Appendix G of NAU’s Student Handbook http://www4.nau.edu/stulife/handbookdishonesty.htm.
ACADEMIC CONTACT HOUR POLICY The Arizona Board of Regents Academic Contact
Hour Police (ABOR handbook, 20296, Academic Credit) states: “an hour of work is the
equivalent of 50 minutes of class time . . . at least 15 contact hours of recitation, lecture,
discussion, testing or evaluation, seminar, or colloquium as well as a minimum of 30 hours of
student homework is required for each unit of credit.”
SENSITIVE COURSE MATERIAL If an instructor believes it is appropriate, the syllabus
should communicate to students that some course content may be considered sensitive by some
students.
“University education aims to expand student understanding and awareness. Thus it necessarily
involves engagement with a wide range of information, ideas, and creative representations. In
the course of college studies, students can expect to encounter – and critically appraise –
materials that may differ from and perhaps challenge familiar understandings, ideas, and beliefs.
Students are encouraged to discuss these matters with faculty.”
Revised 06/22/2011
8